The First Remote Gait Monitoring Platform

For decades, gait was overlooked—evaluated subjectively, infrequently, and too late. Overburdened providers lacked the time, tools, and data to detect early signs of serious conditions like Peripheral Artery Disease (PAD), Parkinson’s Disease, Stroke, and post-surgical complications (e.g., DVT, PE). The result? 75,000 amputations annually from late-stage PAD, missed Parkinson’s diagnoses, and preventable hospitalizations.

Today, gait is finally being recognized as the sixth vital sign—a dynamic biomarker that reflects neurologic, vascular, and musculoskeletal health. But most gait assessments still rely on a trained eye and in-clinic visits, making early detection inconsistent and inaccessible at scale.

Enter Grasshopper Health

Grasshopper is the first wearable platform for Remote Gait Monitoring (RGM). Our disposable patch—worn on the sacrum—passively measures subtle gait abnormalities and transmits them securely to a provider’s EMR. Using AI-powered analysis, we flag early signs of gait-related disease, monitor patient progression, and help providers intervene before complications arise.

Why It Matters

• PAD: 150,000 amputations/year—50% preventable with earlier detection

• Parkinson’s: 30% of 1M+ cases undiagnosed until late stage

• Stroke & DVT/PE: 300,000+ post-surgical complications annually

• Frailty: 250,000 hip fractures/year, often due to unnoticed mobility decline

With RPM reimbursement already in place and a U.S. provider shortfall exceeding 2 million, Grasshopper gives providers a powerful new tool to monitor thousands of patients remotely—with alerts that drive early diagnosis, targeted intervention, and better outcomes.